Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: High-throughput assay by Invader® assay

Journal of Lipid Research

Volumn 43, Issue 7, 2002, Pages 1011-1018

  Nagano, Makoto ^a   Yamashita, Shizuya ^a   Hirano, Ken ichi ^a   Ito, Mayumi ^a   Maruyama, Takao ^a   Ishihara, Mitsuaki ^a   Sagehashi, Yukiko ^a   Oka, Tomoichiro ^a   Kujiraoka, Takeshi ^a   Hattori, Hiroaki ^a   Nakajima, Norimichi ^a   Egashira, Tohru ^a   Kondo, Masatoshi ^a   Sakai, Naohiko ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesteryl ester transfer protein deficiency; Genotyping; HDL cholesterol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HETEROZYGOSITY; HUMAN; HYPERALPHALIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA; INVADER ASSAY; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SECRETION; SITE DIRECTED MUTAGENESIS; AMINO ACID SEQUENCE; BLOOD; CHEMISTRY; ETHNOLOGY; GENETICS; GENOTYPE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADULT; AGED; AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; FEMALE; GENOTYPE; HUMAN; HYPERLIPOPROTEINEMIA; JAPAN; LIPOPROTEINS, HDL CHOLESTEROL; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIAS; MIDDLE AGED;

EID: 0035987264     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200024-JLR200     Document Type: Article

References (43)

1. An overview of reverse cholesterol transport
2. Plasma lipid transfer protein, high-density lipoproteins, and reverse cholesterol transport
3. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
4. Pros and cons of inhibiting cholesteryl ester transfer protein
5. Plasma lipid transfer protein
6. Molecular genetics of plasma cholesteryl ester transfer protein
7. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition
8. Is it time to modify the reverse cholesterol transport model?
9. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
10. Dissociation of lipid-free apolipoprotein A-I form high density lipoproteins
11. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
12. Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation
13. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect
14. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
15. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population; relation between the mutation and hyperalphalipoproteinemia
16. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins
17. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
18. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
19. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA
20. Exon skipping caused by intron 10 splicing donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
21. Point mutation (-69 G→A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
22. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity
23. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency
24. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency
25. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins
26. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan
27. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
28. A low prevalence of cornary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency
29. Purification, microheterogeneity, and stability of human lipid transfer protein
30. Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: Plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients
31. Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer
32. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotides probes
33. Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay
34. Large-scale SNP scoring from unamplified genomic DNA
35. Genotyping single-nucleotide polymorphisms by the Invader assay with dual-color fluorescence polarization detection
36. Estimation of the concentration of the low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
37. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution
38. The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein
39. A hydrophobic cluster at the surface of the human plasma phospholipids transfer protein is critical for activity on high density lipoproteins
40. Identification of mutations in the cholesteryl ester transfer protein in Europeans with elevated high density lipoprotein cholesterol
41. Cloning and sequencing of human cholesteryl ester transfer protein cDNA
42. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia
43. New functional promoter polymorphism CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels; role of Sp1/Sp3 in transcriptional regulation